01 2Asclemed USA, Inc.
02 1Fagron Inc
03 1Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
04 3Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
05 2LETCO MEDICAL, LLC
06 1Medisca Inc.
07 2Pharma Source Direct, Inc.
08 1Productos Quimicos Naturales S.A. de C.V.
09 1Professional Compounding Centers of America dba PCCA
01 1DEHYDROEPIANDROSTERONE
02 1DHEA (Prasterone)
03 1DHEA Micro
04 2Dehydroepiandrosterone
05 1Dehydroepiandrosterone (DHEA)
06 1Dehydroepiandrosterone (Micronized) (DHEA)
07 1Dehydroepiandrosterone Non-Micronized
08 4PRASTERONE
09 1Prasterone
10 1dehydroepiandrosterone
01 4China
02 1Mexico
03 1Netherlands
04 7U.S.A
05 1United Kingdom
NDC Package Code : 51552-0533
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-02-20
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 70492-004
Start Marketing Date : 2018-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64025-0022
Start Marketing Date : 2023-09-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64025-0015
Start Marketing Date : 2009-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64025-0017
Start Marketing Date : 2005-03-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3188
Start Marketing Date : 2023-04-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-3205
Start Marketing Date : 2024-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0733
Start Marketing Date : 2007-02-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-2960
Start Marketing Date : 2020-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12875-9930
Start Marketing Date : 2011-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Prasterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prasterone, including repackagers and relabelers. The FDA regulates Prasterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prasterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prasterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prasterone supplier is an individual or a company that provides Prasterone active pharmaceutical ingredient (API) or Prasterone finished formulations upon request. The Prasterone suppliers may include Prasterone API manufacturers, exporters, distributors and traders.
click here to find a list of Prasterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prasterone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Prasterone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Prasterone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Prasterone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prasterone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Prasterone suppliers with NDC on PharmaCompass.
We have 9 companies offering Prasterone
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
